185
Participants
Start Date
December 31, 2005
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
olmesartan, hydrochlorothiazide, amlodipine
hydrochlorothiazide (HCTZ) 25mg OD, increased to 50 mg OD at 3 weeks. Olmesartan 20 mg OD, to be increased to 40 mg at 3 weeks. Amlodipine 5 mg, may be added at 6 weeks, if BP \>140 mmHg
hydrochlorothiazide (HCTZ) or olmesartan
HCTZ 25 mg, increasing to 50 mg at 3-4 weeks or Olmesartan 20 mg, increasing to 40 mg at 3-4 weeks. If blood pressure \>140/90 mmHg at 6 weeks, amlodipine 5 mg may be added
Lincoln Medical and Mental Health Center, The Bronx
Albert Einstein College of Medicine - GCRC, The Bronx
Jacobi Medical Center, The Bronx
Bronx Nephrology Hypertension, PC, The Bronx
Ralph Yung, MD, The Bronx
Collaborators (1)
Daiichi Sankyo
INDUSTRY
The Louis & Rachel Rudin Foundation
OTHER